MM
Michael R Megna (CHIEF ACCOUNTING OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $3.4M of KNSA (36,260 sh across 7 lots, as filed), executed Oct 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.1M
shares × price, as filed
Last traded
Oct 30
Filed Nov 3
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$203K9,051 sh × $22.45
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $194K
8,637 sh × $22.45
Exec Nov 27 2024
Filed Dec 2 2024 · 5:30 PM ET